Načítá se...
Update on cell therapy for stroke
Ischaemic stroke remains a leading cause of death and disability. Current stroke treatment options aim to minimise the damage from a pending stroke during the acute stroke period using intravenous thrombolytics and endovascular thrombectomy; however, there are no currently approved treatment options...
Uloženo v:
| Vydáno v: | Stroke Vasc Neurol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5600013/ https://ncbi.nlm.nih.gov/pubmed/28959493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2017-000070 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|